ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 469 filers reported holding ENCOMPASS HEALTH CORP in Q2 2024. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $837,857 | -10.4% | 10,146 | -27.6% | 0.04% | -29.0% |
| Q4 2023 | $934,747 | -1.0% | 14,010 | -0.3% | 0.06% | 0.0% |
| Q3 2023 | $944,068 | -0.9% | 14,057 | -0.1% | 0.06% | 0.0% |
| Q2 2023 | $952,544 | +16.1% | 14,068 | -7.2% | 0.06% | +26.5% |
| Q1 2023 | $820,264 | +18.4% | 15,162 | +30.9% | 0.05% | +36.1% |
| Q4 2022 | $692,719 | -19.2% | 11,582 | -38.9% | 0.04% | +16.1% |
| Q3 2022 | $857,000 | -11.1% | 18,943 | +10.2% | 0.03% | +14.8% |
| Q2 2022 | $964,000 | -34.2% | 17,197 | -16.6% | 0.03% | -35.7% |
| Q1 2022 | $1,466,000 | -23.4% | 20,625 | -29.7% | 0.04% | -14.3% |
| Q4 2021 | $1,915,000 | -1.2% | 29,347 | +13.6% | 0.05% | 0.0% |
| Q3 2021 | $1,939,000 | -20.2% | 25,842 | -16.8% | 0.05% | -32.9% |
| Q2 2021 | $2,431,000 | +876.3% | 31,071 | +763.1% | 0.07% | +711.1% |
| Q4 2019 | $249,000 | +2390.0% | 3,600 | +2300.0% | 0.01% | – |
| Q2 2019 | $10,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 697,659 | $45,334,000 | 10.13% |
| JANA PARTNERS LLC | 1,741,513 | $113,164,000 | 10.12% |
| Endurant Capital Management LP | 276,105 | $17,941,000 | 5.31% |
| REINHART PARTNERS, LLC. | 726,140 | $47,184,000 | 3.55% |
| Prosight Management, LP | 107,921 | $7,013,000 | 3.34% |
| Advantage Alpha Capital Partners LP | 160,234 | $10,412,000 | 2.41% |
| RK Capital | 115,800 | $7,525,000 | 2.13% |
| Copeland Capital Management, LLC | 700,015 | $45,487,000 | 2.02% |
| Sivik Global Healthcare LLC | 65,000 | $4,224,000 | 1.82% |
| Walthausen & Co., LLC | 120,016 | $7,799,000 | 1.62% |